Real time 3D ultrasound imaging

No one would deny that having regular check-ups is essential for your health and if you are going to overgo a full examination it is always better to address prfessionals in diagnostic and imaging services. Mnap outpatient radiology diagnostic imaging center is a unique opportunity to be sure that you will get the highest standard of medical care.

If your location is Philadelphia - MNAP can be considered the only opportunity to get outpatient radioloy services of that kind in the whole area as it possesses the highest technology equippment, like Magnetom Avanto and Siemens Magnetom Concerto. Overall the atmosphere in this diagnostic center is friedndly and the specialists are trained in many related radiology medicine areas. Custom approach to all the clients is the biggest advantage over other medical establishments of that kind in Pennsylvania.

Russian magazine “Zdorovie” states that open MRI was especially designed for those patients for who traditional mri machines seem unbearable and they feel rather claustrophobic in them.

MNAP is also called a fullscope women’s diagnostic center as, for instance, mammography services are of the highest level possible with Siemens Mammomat 3000 system.

In 2004 MNAP opened a special center that uses Sandman Sleepware System. Sleep disorders pulmonology center started research in the sphere of sleep apnea, insomnia, restless limb movements and narcolepsy.

1. Researchers warn that men that wear a tie too tight can increase their risk of glaucoma.
2. Roller Coaster fans beware: People who ride on roller coasters have a higher chance of having a blood clot form in the brain.
3. Women that drink alcohol excessively increase their risk of breast cancer.
4. People that suffer from gum disease are twice as likely to have a stroke or heart attack.
5. Surgery patients that are overweight are at higher risk of having a surgical tool left inside the body.
There are approximately 1,500 incidents of this occurrence in the USA each year with the majority of the incidents at the expense of overweight patients.
6. Cell phones increase the likelihood by 2.5 times of developing cancer in areas of the brain that are closest to the ear used to talk on the mobile phone 7. Being struck by lightning increases your chance of developing motor neuron disease.

Sanofi Pasteur, Canada’s largest vaccination company is about to launch the new whooping cough immunization vaccine for workplace and home protection - Adacel. It is scheduled to go out to general use in May. Adacel goes alongside with Sanofi Pasteur’s newest workplace flu shot. It will provide guaranteed protection to Canadians during cold and frosty northern winters.

Sanofi Pasteur is a true innovator in the sphere of Canadian medical treatment. Its innovative bladder cancer treatment medicines and handy travel diarrhea remedies shook the whole pharma market last year. All in all, during the last two years Sanofi Pasteur has extended its line of previously purely vaccination products targeted against dozens of preventable diseases such as influenza, polio, meningitis, diphtheria, tetanus, acellular Pertussis and more.

Sanofi Pasteur was originally founded as the preventable diseases vaccination business of the Sanofi-Aventis Group, the third largest pharmaceutical company in the world.

Canadian Health Ministry official - Michael Mitchell - revealed a new national immunization strategy. Yesterday on Canadian television he stated that both houses of Parliament are reviewing the National Immunization Strategy (NIS) initiative, which is focused mainly on making Meningitis and Hepatitis A vaccination obligatory in all Canadian public and private schools.

The NIS has assisted the vaccination program planning in Canada since 2003, being based on the idea that all issues connected with immunization must be on the forefront of the Canadian public health agenda. This initiative is also backed and lobbied by Canada’s largest vaccination company, the developers of various well-known immunization shots like Vivaxim, Adacel, Menactra or Immucyst- Sanofi Pasteur.

Latest Toronto Star’s articles assess the probability of NIS to be endorsed as “reasonably high”. Political reviewers expect the initiative to be approved in the first reading, having no exact financing figures for it specified. The National Immunization Strategy initiative will be discussed in Ottawa in the beginning of May. If approved, it may go in effect in September 2008, just with the new schoolyear.

Major depression, the kind of depression that will most likely benefit from treatment with medications, is more than just “the blues.” It is a condition that lasts 2 weeks or more, and interferes with a person’s ability to carry on daily tasks and enjoy activities that previously brought pleasure. Depression is associated with abnormal functioning of the brain. An interaction between genetic tendency and life history appears to determine a person’s chance of becoming depressed. Episodes of depression may be triggered by stress, difficult life events, side effects of medications, or medication/substance withdrawal, or even viral infections that can affect the brain.

Depressed people will seem sad, or “down,” or may be unable to enjoy their normal activities. They may have no appetite and lose weight (although some people eat more and gain weight when depressed). They may sleep too much or too little, have difficulty going to sleep, sleep restlessly, or awaken very early in the morning. They may speak of feeling guilty, worthless, or hopeless; they may lack energy or be jumpy and agitated. They may think about killing themselves and may even make a suicide attempt. Some depressed people have delusions (false, fixed ideas) about poverty, sickness, or sinfulness that are related to their depression. Often feelings of depression are worse at a particular time of day, for instance, every morning or every evening.

Not everyone who is depressed has all these symptoms, but everyone who is depressed has at least some of them, co-existing, on most days. Depression can range in intensity from mild to severe. Depression can co-occur with other medical disorders such as cancer, heart disease, stroke, Parkinson’s disease, Alzheimer’s disease, and diabetes. In such cases, the depression is often overlooked and is not treated. If the depression is recognized and treated, a person’s quality of life can be greatly improved.

Antidepressants are used most often for serious depressions, but they can also be helpful for some milder depressions. Antidepressants are not “uppers” or stimulants, but rather take away or reduce the symptoms of depression and help depressed people feel the way they did before they became depressed.

The doctor chooses an antidepressant based on the individual’s symptoms. Some people notice improvement in the first couple of weeks; but usually the medication must be taken regularly for at least 6 weeks and, in some cases, as many as 8 weeks before the full therapeutic effect occurs. If there is little or no change in symptoms after 6 or 8 weeks, the doctor may prescribe a different medication or add a second medication such as lithium, to augment the action of the original antidepressant. Because there is no way of knowing beforehand which medication will be effective, the doctor may have to prescribe first one and then another. To give a medication time to be effective and to prevent a relapse of the depression once the patient is responding to an antidepressant, the medication should be continued for 6 to 12 months, or in some cases longer, carefully following the doctor’s instructions. When a patient and the doctor feel that medication can be discontinued, withdrawal should be discussed as to how best to taper off the medication gradually. Never discontinue medication without talking to the doctor about it. For those who have had several bouts of depression, long-term treatment with medication is the most effective means of preventing more episodes.

Dosage of antidepressants varies, depending on the type of drug and the person’s body chemistry, age, and, sometimes, body weight. Traditionally, antidepressant dosages are started low and raised gradually over time until the desired effect is reached without the appearance of troublesome side effects. Newer antidepressants may be started at or near therapeutic doses.

Early Antidepressants. From the 1960s through the 1980s, tricyclic antidepressants (named for their chemical structure) were the first line of treatment for major depression. Most of these medications affected two chemical neurotransmitters, norepinephrine and serotonin. Though the tricyclics are as effective in treating depression as the newer antidepressants, their side effects are usually more unpleasant; thus, today tricyclics such as imipramine, amitriptyline, nortriptyline, and desipramine are used as a second- or third-line treatment. Other antidepressants introduced during this period were monoamine oxidase inhibitors (MAOIs). MAOIs are effective for some people with major depression who do not respond to other antidepressants. They are also effective for the treatment of panic disorder and bipolar depression. MAOIs approved for the treatment of depression are phenelzine (Nardil), tranylcypromine (Parnate), and isocarboxazid (Marplan). Because substances in certain foods, beverages, and medications can cause dangerous interactions when combined with MAOIs, people on these agents must adhere to dietary restrictions. This has deterred many clinicians and patients from using these effective medications, which are in fact quite safe when used as directed.

The past decade has seen the introduction of many new antidepressants that work as well as the older ones but have fewer side effects. Some of these medications primarily affect one neurotransmitter, serotonin, and are called >selective serotonin reuptake inhibitors (SSRIs). These include fluoxetine (Prozac), sertraline (Zoloft), fluvoxamine (Luvox), paroxetine (Paxil), and citalopram (Celexa).

The late 1990s ushered in new medications that, like the tricyclics, affect both norepinephrine and serotonin but have fewer side effects. These new medications include venlafaxine (Effexor) and nefazadone (Serzone).

Cases of life-threatening hepatic failure have been reported in patients treated with nefazodone (Serzone). Patients should call the doctor if the following symptoms of liver dysfunction occur—yellowing of the skin or white of eyes, unusually dark urine, loss of appetite that lasts for several days, nausea, or abdominal pain.

Other newer medications chemically unrelated to the other antidepressants are the sedating mirtazepine (Remeron) and the more activating bupropion (Wellbutrin). Wellbutrin has not been associated with weight gain or sexual dysfunction but is not used for people with, or at risk for, a seizure disorder.

Read the rest of this entry »